Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Men over the age of 40
- Men who have prostate cancer that has not spread beyond the prostate, and who are having a specific type of biopsy performed (either a transperineal template biopsy or an MRI-guided biopsy combined with a systematic biopsy)
- Men whose cancer is at an early stage (classified as T1–T2c), with no spread to lymph nodes or other parts of the body, a PSA blood test result below 20 ng/ml, and a Gleason score of 7 or lower — or men whose cancer is assessed by the research doctor as low-to-medium risk within a similar early stage (confirm with trial site)
- Men who are receiving treatment with either a HIFU device (high-intensity focused ultrasound delivered via a rectal probe) or a robot-assisted keyhole surgery to remove the prostate
Who may not be able to join:
- Men who have had an active infection of the urinary or genital system within 100 days before their surgery
- Men who have previously had radiation therapy
- Men who have certain abnormal blood test results before surgery, including elevated liver enzyme levels (ALT, AST, or alkaline phosphatase more than 3 times the normal upper limit), blood clotting problems, or a history of another cancer — though men with a history of cancer that has not come back in the last 5 years may still be considered, and certain skin cancers may be exceptions (confirm with trial site)
- Men who have a metal implant or stent inside the urethra (the tube that carries urine)
- Men whose prostate cancer is located at the front tip of the prostate or in a position that cannot be safely reached by the treatment, or where important surrounding organs would block the treatment path
- Men who the research doctor considers unsuitable for the trial for other reasons, such as significant mental health or emotional difficulties, or problems with hearing, speaking, reading, writing, or following a treatment plan
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Xue Wei, Doctor's, RenJi Hospital
Phone: 13917826792
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Incidence of postoperative complications
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.